FindTrial
Sign In

The impact of genetic polymorphisms on clinical efficacy of aspirin in patients with acute ischemic stroke

The impact of genetic polymorphisms on clinical efficacy of aspirin in patients with acute ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002951
Enrollment
Unknown
Registered
2012-12-30
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral infarction

Interventions

The patients will be allocated by genetype:Statins

Sponsors

Department of Neurology, Affiliated Drum Tower Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: acute cerebral infarction

Exclusion criteria

Exclusion criteria: exposure to thienopyridine or GP IIb/IIIa inhibitor within one week; cerebral embolism; intracranial hemorrhage after cerebral infarction

Design outcomes

Primary

MeasureTime frame
platelet aggregation;genotypy;—

Countries

China

Contacts

Public ContactYun Xu
xuyun20042001@yahoo.com.cn+86 25 8310-5208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026